查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827832

2025年全球自行注射市场报告

Self-Injections Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，自行注射市场规模强劲成长，从2024年的96.9亿美元增加至2025年的102.2亿美元，复合年增长率为5.5%。这段期间的成长可归因于慢性病发病率的上升、患者自主权的增强、监管机构的支持、对家庭医疗保健的偏好以及成本效益。

预计未来几年自行注射市场规模将强劲成长，到2029年将达到139.3亿美元，复合年增长率为8.1%。预测期内的成长可归因于疫情和远端医疗的影响、新兴市场的扩张、以患者为中心的医疗保健、药物输送优势以及个人化医疗趋势。预测期内的主要趋势包括智慧技术的整合、生技药品应用的增加、微型化和穿戴式装置、安全性能的增强以及自动注射器的普及。

自行注射是指个人在没有医疗保健专业人员协助的情况下透过设备自行注射药物的行为，允许患者独立管理他们的药物治疗。

自行注射的主要类型包括装置和剂型。这些装置可让患者自行注射需要注射的药物，而无需依赖医疗专业人员。自动注射器可用于多种给药途径，包括皮肤、循环系统、肌肉骨骼系统、器官和中枢神经系统。剂量类型包括单剂量和多剂量，并适用于自体免疫疾病、荷尔蒙失调、肿瘤学、罕见疾病、疼痛管理和呼吸治疗等应用。这些装置透过各种管道销售，包括医院、药房、诊所、药局和线上药局。

2025年春季，美国关税飙升及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快研发更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供自行注射市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的自行注射自行注射市场细分、市场趋势和机会，以及在自行注射行业取得成功所需的其他数据。本自行注射市场研究报告对该行业的自行注射和未来趋势进行了详细分析，提供了所有必要的完整观点。

未来五年预测成长率为8.1%，较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国，导致自动注射器弹簧和剂量计数装置（主要由瑞典和丹麦供应）以及慢性病管理设备的成本上升。此外，由于相互关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛。

预计未来糖尿病患者数量的成长将推动自行注射市场的成长。糖尿病是一种疾病，胰臟（负责产生胰岛素的器官）分泌的胰岛素不足，会导致血糖值下降，并引发心臟病、视力丧失和肾臟疾病等严重健康问题。自行注射使糖尿病患者能够自行注射胰岛素和其他药物，有助于调节血糖值，并防止糖分摄取过量，无需医疗专业人员的协助。例如，根据总部位于比利时的全球糖尿病盛行率、治疗和护理综合数据资讯来源IDF糖尿病地图集的数据，预计全球糖尿病患者数量将从2030年的6.43亿增加1.4亿，到2045年将达到7.83亿。目前，全球有5.37亿成年人患有糖尿病，其中超过75%居住在中低收入国家。因此，糖尿病患者数量的增加将显着促进自行注射市场的扩张。

远端保健和远端医疗的兴起预计将在未来推动自行注射市场的成长。远端医疗利用通讯技术远端提供广泛的医疗服务和讯息，而远端医疗则专注于远距临床咨询和医疗服务。这些数位健康平台支援虚拟咨询，并允许医疗保健提供者远端准备自行注射药物。患者还可以从有关如何正确进行自行注射的虚拟训练课程中受益。此外，远端医疗有助于即时监控患者的用药依从性、持续的疾病管理以及轻鬆存取远端药房服务进行药物分配。远端医疗的便利性，尤其是在大流行期间，提高了患者的参与度并改善了获得专科护理的整体机会，极大地促进了自行注射市场的成长。例如，根据美国政府资讯提供者Telehealth.HHS.gov的数据，2023年第四季远端保健使用者数量达到约21,883,731人，较上一季增加2,783,159人（13%）。因此，远端保健和远端医疗的兴起正在推动自行注射市场的扩张。

胰岛素注射解决方案的创新是自行注射市场的关键趋势，领先的公司专注于开发新产品以增强其竞争地位。例如，2022 年 9 月，日本医疗设备製造商Terumo Corporation推出了 FineGlide，这是一款无菌笔式针头，专为需要定期注射胰岛素和其他自我治疗的患者设计。 FineGlide 将患者的舒适度放在首位，采用三斜面超锋利针头和优质硅胶表面，确保注射轻柔。薄壁技术的加入提高了流速并减少了注射力，提高了患者的整体舒适度并促进了用药依从性。这种对产品创新的关注表明了领先公司致力于满足自行注射市场患者不断变化的需求。

自行注射市场包括自动注射器、无针注射器、笔式註射器和穿戴式註射器的销售。该市场的价值指的是“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球自行注射：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球自行注射市场：成长率分析
  • 全球自行注射市场表现：规模与成长，2019-2024
  • 全球自行注射市场预测：规模与成长，2024-2029 年，2034 年
  • 全球自行注射：总可寻址市场（TAM）

第六章 市场细分

  • 全球自行注射市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 装置
  • 配方
  • 全球自行注射市场（依给药途径）：2019-2024 年、2024-2029 年、2034 年表现与预测
  • 皮肤
  • 循环系统或肌肉骨骼系统
  • 器官
  • 中枢神经系统
  • 全球自行注射市场（按剂量、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 单一剂量
  • 多剂量
  • 全球自行注射市场的应用、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 自体免疫疾病
  • 荷尔蒙失调
  • 肿瘤学
  • 罕见疾病
  • 疼痛管理
  • 呼吸治疗
  • 其他的
  • 全球自行注射市场（依通路）：2019-2024 年、2024-2029 年、2034 年业绩及预测
  • 医院药房
  • 诊所
  • 化学家
  • 网路药局
  • 全球自行注射市场：设备细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 预填充式注射器
  • 自动注射器
  • 微针装置
  • 穿戴式註射器
  • 全球自行注射市场：配方细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 生技药品
  • 疫苗
  • 小分子
  • 组合产品

第七章 区域和国家分析

  • 全球自行注射市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球自行注射市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 自行注射市场：竞争格局
  • 自行注射市场：公司简介
    • AbbVie Inc.
    • Antares Pharma Inc.
    • Baxter International Inc.
    • Bayer AG
    • Becton Dickinson and Company

第31章：其他领先和创新企业

  • Bristol-Myers Squibb Company
  • Credence MedSystems Inc.
  • Dali Medical Devices Ltd.
  • Eli Lilly and Company
  • Enable Injections Inc.
  • Gerresheimer AG
  • Insulet Corporation
  • Merck & Co. Inc.
  • Owen Mumford Limited
  • Pfizer Inc.
  • PharmaJet Inc.
  • Recipharm AB
  • Schott AG
  • SHL Group Limited
  • Terumo Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年自行注射市场：提供新机会的国家
  • 2029 年自行注射市场：细分市场带来新机会
  • 2029年自行注射市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r22934u

Self-injection refers to the act of administering medications or drugs through a device by an individual to themselves without the assistance of a medical professional. This practice allows patients to independently manage their medication regimen.

The primary types of self-injections encompass devices and formulations. These devices enable patients to self-administer medications that require injection without relying on medical professionals. Self-injection devices are utilized for various routes of administration such as skin, circulatory or musculoskeletal systems, organs, and the central nervous system. Dosage types include single-dose and multi-dose, catering to applications in autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, among others. These devices are distributed through various channels including hospitals, pharmacies, clinics, chemists, and online pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The self injections market research report is one of a series of new reports from The Business Research Company that provides self injections market statistics, including self injections industry global market size, regional shares, competitors with a self injections market share, detailed self injections market segments, market trends and opportunities, and any further data you may need to thrive in the self injections industry. This self injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The self-injections market size has grown strongly in recent years. It will grow from $9.69 billion in 2024 to $10.22 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to rising chronic diseases, improved patient empowerment, regulatory support, preference for home healthcare, cost-effectiveness.

The self-injections market size is expected to see strong growth in the next few years. It will grow to $13.93 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to pandemic impact and remote treatment, expansion into emerging markets, patient-centric healthcare, advantages in drug delivery, personalized medicine trends. Major trends in the forecast period include smart technology integration, rise in biologics usage, miniaturization and wearable devices, enhanced safety features, adoption of autoinjectors.

The forecast of 8.1% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher costs for autoinjector springs and dose-counting mechanisms, predominantly supplied by Sweden and Denmark, impacting chronic disease management devices.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing number of diabetic patients is anticipated to drive the growth of the self-injections market in the future. Diabetes is a condition where the pancreas, an organ responsible for producing insulin, generates an insufficient amount of insulin, leading to the breakdown of blood sugar and resulting in severe health conditions such as heart disease, vision loss, and kidney disease. Self-injections allow diabetic patients to administer insulin and other medications themselves, helping to regulate blood sugar levels and prevent excess sugar without the need for assistance from a medical professional. For example, according to the IDF Diabetes Atlas, a Belgium-based global resource offering comprehensive data on diabetes prevalence, treatment, and care, the global number of diabetes cases is expected to rise from 643 million in 2030 to 783 million by 2045, an increase of 140 million cases. Currently, 537 million adults live with diabetes, with more than 75% residing in low- and middle-income countries. Therefore, the growing number of diabetic patients is significantly contributing to the expansion of the self-injections market.

The rise of telehealth and telemedicine is expected to drive the growth of the self-injections market in the future. Telehealth involves the use of telecommunications technology to deliver a wide range of healthcare services and information remotely, while telemedicine focuses specifically on remote clinical consultations and healthcare delivery. These digital health platforms enable virtual consultations, allowing healthcare providers to prescribe self-injectable medications from a distance. Patients also benefit from virtual training sessions that ensure they administer self-injections correctly. Additionally, telehealth facilitates real-time monitoring of patient adherence, ongoing disease management, and easy access to telepharmacy services for medication delivery. The convenience of telehealth, especially during pandemics, enhances patient engagement and improves overall access to specialized care, significantly contributing to the growth of the self-injections market. For example, according to Telehealth.HHS.gov, a U.S. government information provider, telehealth usage reached approximately 21,883,731 users in Q4 2023, marking an increase of 2,783,159 users, or 13%, compared to the previous quarter. Thus, the increase in telehealth and telemedicine is driving the expansion of the self-injections market.

Innovation in insulin injection solutions is a key trend in the self-injections market, with major companies focusing on developing new products to gain a competitive edge. For example, in September 2022, Terumo Corporation, a Japan-based medical device company, launched FineGlide, a sterile pen needle designed for patients requiring regular insulin injections or other self-medication. FineGlide prioritizes patient comfort by featuring a 3-bevel super sharp needle with a high-grade silicone surface, ensuring gentleness during injections. The inclusion of Thin Wall Technology improves flow rate and reduces injection force, enhancing the overall experience for patients and promoting drug compliance. This focus on product innovation demonstrates the commitment of major companies to meet the evolving needs of patients in the self-injections market.

Major players in the self-injections market are focusing on the development of smart injecting devices to gain a competitive advantage. In March 2022, Pfizer Inc., a prominent US-based pharmaceutical company, introduced ENBREL SmartClic in Australia. This innovative self-injecting device is designed for patients undergoing treatment with ENBREL, a tumor necrosis factor (TNF) inhibitor prescribed for conditions like Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), and Psoriatic Arthritis (PsA). ENBREL SmartClic features an automated, reusable design with user-friendly elements, including a one-button initiation, a larger grip compared to the Enbrel Auto-Injector, and injection speed control. The device is accompanied by a smartphone app, providing additional features such as reminders, injection history recording, site tracking, and streamlined reports. Patients can access these features on their smartphones and share the information with healthcare professionals, enhancing the overall self-injection experience for those dealing with chronic inflammatory diseases.

In June 2022, Dr. Reddy Labs, an India-based pharmaceutical manufacturer, made a significant acquisition by purchasing an injectable portfolio from Eton Pharma for $50 million. This strategic move by Dr. Reddy's aimed to accelerate and expand the availability of affordable medications for patients. The acquisition included new portfolios such as injections and recipes, allowing Dr. Reddy's to diversify its product offerings and strengthen its position in the pharmaceutical market. Eton Pharma, a US-based pharmaceutical manufacturer, contributed to Dr. Reddy's efforts to broaden its pharmaceutical portfolio, signaling a strategic expansion into injectable medications.

Major companies operating in the self-injections market are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.

North America was the largest region in the self injections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the self-injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The self injections market consists of sales of auto-injectors, needle-free injectors, pen injectors and wearable injectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Self-Injections Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on self-injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for self-injections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The self-injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Devices; Formulations
  • 2) By Route Of Administration: Skin; Circulatory Or Musculoskeletal; Organs; Central Nervous System
  • 3) By Dosage: Single Dose; Multi Dose
  • 4) By Application: Autoimmune Diseases; Hormonal Disorders; Oncology; Orphan Diseases; Pain Management; Respiratory Therapy; Other Applications
  • 5) By Distribution Channel: Hospitals Pharmacies; Clinics; Chemist; Online Pharmacies
  • Subsegments:
  • 1) By Devices: Pre-Filled Syringes; Auto-Injectors; Microneedle Devices; Wearable Injectors
  • 2) By Formulations: Biologics; Vaccines; Small Molecules; Combination Products
  • Companies Mentioned: AbbVie Inc.; Antares Pharma Inc.; Baxter International Inc.; Bayer AG; Becton Dickinson and Company; Bristol-Myers Squibb Company; Credence MedSystems Inc.; Dali Medical Devices Ltd.; Eli Lilly and Company; Enable Injections Inc.; Gerresheimer AG; Insulet Corporation; Merck & Co. Inc.; Owen Mumford Limited; Pfizer Inc.; PharmaJet Inc.; Recipharm AB; Schott AG; SHL Group Limited; Terumo Corporation; West Pharmaceutical Services Inc.; Wilhelm Haselmeier GmbH & Co. KG; Ypsomed Holding AG; APTAR PHARMA INDIA PVT LTD; Bespak Europe Ltd.; Bioject Medical Technologies Inc.; Catalent Inc.; Crossject SA; Injex Pharma AG; Medeca Pharma AB; Medimop Medical Projects Ltd.; Mylan N.V.; Nemera Development S.A.; Noble Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Self-Injections Market Characteristics

3. Self-Injections Market Trends And Strategies

4. Self-Injections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Self-Injections Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Self-Injections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Self-Injections Market Growth Rate Analysis
  • 5.4. Global Self-Injections Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Self-Injections Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Self-Injections Total Addressable Market (TAM)

6. Self-Injections Market Segmentation

  • 6.1. Global Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Devices
  • Formulations
  • 6.2. Global Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Skin
  • Circulatory Or Musculoskeletal
  • Organs
  • Central Nervous System
  • 6.3. Global Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Dose
  • Multi Dose
  • 6.4. Global Self-Injections Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autoimmune Diseases
  • Hormonal Disorders
  • Oncology
  • Orphan Diseases
  • Pain Management
  • Respiratory Therapy
  • Other Applications
  • 6.5. Global Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals Pharmacies
  • Clinics
  • Chemist
  • Online Pharmacies
  • 6.6. Global Self-Injections Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pre-Filled Syringes
  • Auto-Injectors
  • Microneedle Devices
  • Wearable Injectors
  • 6.7. Global Self-Injections Market, Sub-Segmentation Of Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biologics
  • Vaccines
  • Small Molecules
  • Combination Products

7. Self-Injections Market Regional And Country Analysis

  • 7.1. Global Self-Injections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Self-Injections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Self-Injections Market

  • 8.1. Asia-Pacific Self-Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Self-Injections Market

  • 9.1. China Self-Injections Market Overview
  • 9.2. China Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Self-Injections Market

  • 10.1. India Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Self-Injections Market

  • 11.1. Japan Self-Injections Market Overview
  • 11.2. Japan Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Self-Injections Market

  • 12.1. Australia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Self-Injections Market

  • 13.1. Indonesia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Self-Injections Market

  • 14.1. South Korea Self-Injections Market Overview
  • 14.2. South Korea Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Self-Injections Market

  • 15.1. Western Europe Self-Injections Market Overview
  • 15.2. Western Europe Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Self-Injections Market

  • 16.1. UK Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Self-Injections Market

  • 17.1. Germany Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Self-Injections Market

  • 18.1. France Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Self-Injections Market

  • 19.1. Italy Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Self-Injections Market

  • 20.1. Spain Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Self-Injections Market

  • 21.1. Eastern Europe Self-Injections Market Overview
  • 21.2. Eastern Europe Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Self-Injections Market

  • 22.1. Russia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Self-Injections Market

  • 23.1. North America Self-Injections Market Overview
  • 23.2. North America Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Self-Injections Market

  • 24.1. USA Self-Injections Market Overview
  • 24.2. USA Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Self-Injections Market

  • 25.1. Canada Self-Injections Market Overview
  • 25.2. Canada Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Self-Injections Market

  • 26.1. South America Self-Injections Market Overview
  • 26.2. South America Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Self-Injections Market

  • 27.1. Brazil Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Self-Injections Market

  • 28.1. Middle East Self-Injections Market Overview
  • 28.2. Middle East Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Self-Injections Market

  • 29.1. Africa Self-Injections Market Overview
  • 29.2. Africa Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Self-Injections Market Competitive Landscape And Company Profiles

  • 30.1. Self-Injections Market Competitive Landscape
  • 30.2. Self-Injections Market Company Profiles
    • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Antares Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Self-Injections Market Other Major And Innovative Companies

  • 31.1. Bristol-Myers Squibb Company
  • 31.2. Credence MedSystems Inc.
  • 31.3. Dali Medical Devices Ltd.
  • 31.4. Eli Lilly and Company
  • 31.5. Enable Injections Inc.
  • 31.6. Gerresheimer AG
  • 31.7. Insulet Corporation
  • 31.8. Merck & Co. Inc.
  • 31.9. Owen Mumford Limited
  • 31.10. Pfizer Inc.
  • 31.11. PharmaJet Inc.
  • 31.12. Recipharm AB
  • 31.13. Schott AG
  • 31.14. SHL Group Limited
  • 31.15. Terumo Corporation

32. Global Self-Injections Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Self-Injections Market

34. Recent Developments In The Self-Injections Market

35. Self-Injections Market High Potential Countries, Segments and Strategies

  • 35.1 Self-Injections Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Self-Injections Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Self-Injections Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer